Discover Q2 2025 highlights from Royalty Pharma (RPRX): double-digit growth, raised guidance, a $2B partnership, efficient cost structure, & ...

Maven Capital Partners has sold UAP, a designer and supplier of door and window hardware, to global security and access ...

The royalty aggregator’s proposed deals for HilleVax and Lava add to a pattern of “zombie” biotech buyouts this year as the ...

Detailed price information for KKR & Company LP (KKR-N) from The Globe and Mail including charting and trades.

Q2 2025 Earnings Call Transcript July 31, 2025 KKR & Co. Inc. beats earnings expectations. Reported EPS is $1.18, ...

Q2 2025 Management View Co-CEO Scott C. Nuttall highlighted the company's strong performance, stating that fee-related earnings per share reached $0.98, total operating earnings were $1.33 per share, ...

Investment giant KKR reported a 9% rise in adjusted net income for the second quarter on Thursday, bolstered by an ...

KKR executives said strong momentum in their business gave them confidence on Thursday of beating earnings targets for 2026, ...